Clinical trials
Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,130 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 10 |
| 2001 | 7 |
| 2002 | 32 |
| 2003 | 44 |
| 2004 | 34 |
| 2005 | 60 |
| 2006 | 41 |
| 2007 | 64 |
| 2008 | 56 |
| 2009 | 40 |
| 2010 | 40 |
| 2011 | 54 |
| 2012 | 57 |
| 2013 | 58 |
| 2014 | 36 |
| 2015 | 34 |
| 2016 | 51 |
| 2017 | 37 |
| 2018 | 32 |
| 2019 | 22 |
| 2020 | 33 |
| 2021 | 40 |
| 2022 | 41 |
| 2023 | 34 |
| 2024 | 55 |
| 2025 | 31 |
| 2026 | 36 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 862 |
| Unknown status | 83 |
| Terminated | 61 |
| Recruiting | 46 |
| Active, not recruiting | 24 |
| Not yet recruiting | 23 |
| Withdrawn | 21 |
| Enrolling by invitation | 8 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Organon and Co | 87 |
| AstraZeneca | 59 |
| Sanofi | 37 |
| Amgen | 35 |
| National Heart, Lung, and Blood Institute (NHLBI) | 30 |
| Merck Sharp & Dohme LLC | 27 |
| Novartis Pharmaceuticals | 23 |
| Pfizer | 17 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 17 |
| Esperion Therapeutics, Inc. | 15 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 1,130 |
| Dyslipidemias | 139 |
| Hyperlipidemias | 139 |
| Hypertension | 139 |
| Cardiovascular Diseases | 129 |
| Diabetes Mellitus | 100 |
| Atherosclerosis | 83 |
| Obesity | 72 |
| Hyperlipoproteinemia Type II | 57 |
| Coronary Disease | 54 |
Trials
Showing 1 to 25 of 1,130. Each trial links to its page on Pharma Observatory.
1,030 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.